Literature DB >> 6458814

Hypersensitivity to N-methyl-N'-nitro-N-nitrosoguanidine in fibroblasts from patients with Huntington disease, familial dysautonomia, and other primary neuronal degenerations.

D A Scudiero, S A Meyer, B E Clatterbuck, R E Tarone, J H Robbins.   

Abstract

Cells from patients with ataxia telangiectasia, a rare autosomal recessive disease characterized by primary neuronal degeneration, are abnormally sensitive to the DNA-damaging chemical N-methyl-N'-nitro-N-nitrosoguanidine. We have conducted experiments to determine whether more common primary neuronal degenerations also have a hypersensitivity to this radiomimetic chemical. Fibroblast strains from 13 control donors and from 13 patients with inherited primary neuronal degenerations were treated in vitro with the chemical, and the strains' sensitivity to the chemical was then determined by measuring their ability to divide and form colonies. Twelve of the 13 patient strains, including the 6 Huntington disease and the 4 familial dysautonomia strains, were abnormally sensitive. This hypersensitivity, which is believed to reflect defective repair of the chemically-induced DNA damage, might provide the basis for presymptomatic and prenatal diagnostic tests for these disorders and for elucidating their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6458814      PMCID: PMC349057          DOI: 10.1073/pnas.78.10.6451

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Some unusual findings in a family with Friedreich's ataxia.

Authors:  P E SYLVESTER
Journal:  Arch Dis Child       Date:  1958-06       Impact factor: 3.791

2.  Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair.

Authors:  J H Robbins; K H Kraemer; M A Lutzner; B W Festoff; H G Coon
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

3.  Presymptomatic diagnosis of Huntington's disease?

Authors:  C F Arlett
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

4.  Identification of ataxia telangiectasia heterozygotes, a cancer prone population.

Authors:  P C Chen; M F Lavin; C Kidson; D Moss
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

5.  Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-irradiation.

Authors:  M C Paterson; A K Anderson; B P Smith; P J Smith
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

6.  Survey of radiosensitivity in a variety of human cell strains.

Authors:  C F Arlett; S A Harcourt
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

7.  Quantification of chemical mutagenesis in diploid human fibroblasts: induction of azaguanine-resistant mutants by N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  L Jacobs; R Demars
Journal:  Mutat Res       Date:  1978-02       Impact factor: 2.433

8.  Decreased DNA repair synthesis and defective colony-forming ability of ataxia telangiectasia fibroblast cell strains treated with N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  D A Scudiero
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

9.  Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation.

Authors:  A D Andrews; S F Barrett; J H Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

10.  Radiosensitivity in Huntington's disease: implications for pathogenesis and presymptomatic diagnosis.

Authors:  A N Moshell; R E Tarone; S F Barrett; J H Robbins
Journal:  Lancet       Date:  1980-01-05       Impact factor: 79.321

View more
  9 in total

Review 1.  Chromatin regulation of DNA damage repair and genome integrity in the central nervous system.

Authors:  Ling Pan; Jay Penney; Li-Huei Tsai
Journal:  J Mol Biol       Date:  2014-08-14       Impact factor: 5.469

2.  Cellular hypersensitivity to ionising radiation in Friedreich's ataxia.

Authors:  R A Brumback
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-09       Impact factor: 10.154

Review 3.  The current state of research with peripheral tissues in Huntington disease.

Authors:  G C Beverstock
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion.

Authors:  P K Liu; C Y Hsu; M Dizdaroglu; R A Floyd; Y W Kow; A Karakaya; L E Rabow; J K Cui
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

5.  Hypersensitivity to DNA-damaging agents in cultured cells from patients with Usher's syndrome and Duchenne muscular dystrophy.

Authors:  J H Robbins; D A Scudiero; F Otsuka; R E Tarone; R A Brumback; J D Wirtschafter; R J Polinsky; S F Barrett; A N Moshell; R G Scarpinato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-04       Impact factor: 10.154

6.  Studies of cellular radiosensitivity in hereditary disorders of nervous system and muscle.

Authors:  S Brennan; P D Lewis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-12       Impact factor: 10.154

7.  Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines.

Authors:  J H Robbins; F Otsuka; R E Tarone; R J Polinsky; R A Brumback; L E Nee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

Review 8.  DNA Repair in Huntington's Disease and Spinocerebellar Ataxias: Somatic Instability and Alternative Hypotheses.

Authors:  Tamara Maiuri; Claudia L K Hung; Celeste Suart; Nola Begeja; Carlos Barba-Bazan; Yi Peng; Natasha Savic; Timothy Wong; Ray Truant
Journal:  J Huntingtons Dis       Date:  2021

Review 9.  The central role of DNA damage and repair in CAG repeat diseases.

Authors:  Thomas H Massey; Lesley Jones
Journal:  Dis Model Mech       Date:  2018-01-30       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.